American International Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

American International Group’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-13,547	Closed	-$52K	–	3188
2020 Q1	$52K	Sell	13,547 -784	-5%	-$3.64K	﹤0.01%	2666
2019 Q4	$87K	Sell	14,331 -120	-0.8%	-$821	﹤0.01%	2703
2019 Q3	$109K	Buy	14,451 +1,231	+9%	+$13.9K	﹤0.01%	2563
2019 Q2	$179K	Buy	+13,220	New	+$153K	﹤0.01%	2300
2018 Q2	–	Sell	-7,457	Closed	-$65K	–	3134
2018 Q1	$65K	Sell	7,457 -400	-5%	-$4.31K	﹤0.01%	2833
2017 Q4	$98K	Buy	7,857 +213	+3%	+$2.44K	﹤0.01%	2745
2017 Q3	$64K	Buy	7,644 +571	+8%	+$6.04K	﹤0.01%	2768
2017 Q2	$120K	Buy	+7,073	New	+$141K	﹤0.01%	2613
2016 Q2	–	Sell	-2,003	Closed	-$19K	–	4599
2016 Q1	$19K	Buy	+2,003	New	+$16.2K	﹤0.01%	4324

Other funds holding ZYNE

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

ZCA

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American International Group's ZYNE Position: Q2 2020 in Review

American International Group sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2020, closing a stake of 13,547 shares — an estimated $52K sold.

American International Group first reported a position in ZYNE in Q1 2016 and held it in 9 quarters. The position peaked at $179K in Q2 2019. 74 funds tracked by Wall St. Rank hold ZYNE as of Q2 2020.

American International Group reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2020 after selling out during the quarter.
American International Group sold 13,547 Zynerba Pharmaceuticals, Inc shares in Q2 2020, an estimated $52K.
American International Group first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2016 and held it in 9 quarters.
American International Group's Zynerba Pharmaceuticals, Inc position peaked at $179K in Q2 2019.
74 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2020.

Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.